Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 4.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.04p
  • 52 Week Low: 1.73p
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 835,434
  • Market Cap: £9.52m

Omega Diagnostics awarded ISO compliance

By Josh White

Date: Wednesday 11 Jan 2017

LONDON (ShareCast) - (ShareCast News) - Medical diagnostics company Omega announced on Thursday that its fully owned Indian subsidiary, Omega Dx Asia, has received certificates of accreditation from BSI confirming its Quality Management System is compliant with the ISO 9001:2008 and ISO 13485:2003 standards.
The AIM-traded firm said the accreditation covers the manufacturing facility in Pune and ensures that product originating from this site is designed, manufactured and supplied to internationally recognised quality standards.

It said the milestone is an important prerequisite for CE-Marking the malaria and pregnancy tests produced at the site.

CE-Marking is still expected to be achieved by the end of the current financial year, the board said.

The board added that accreditation also means that products can be supplied for the Indian domestic market with immediate effect, and said the first commercial sale of one of the company's malaria tests has now been achieved.

"We are pleased to have reached this milestone on schedule and look forward to generating a return from the investment to date in this facility," said CEO Andrew Shepherd.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price 4.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.04p
52 Week Low 1.73p
Volume 835,434
Shares Issued 237.95m
Market Cap £9.52m

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average89.11% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average
Income Not Available
Growth
45.57% below the market average45.57% below the market average45.57% below the market average45.57% below the market average45.57% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average

CNSL Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
15:44 250,000 @ 3.90p
14:57 22,178 @ 4.04p
12:39 100,000 @ 4.00p
11:41 720 @ 3.91p
10:44 2,500 @ 4.00p

CNSL Key Personnel

CEO Jag Grewal
Chair Simon Gordon Douglas

Top of Page